𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Role of β-catenin in the adult liver

✍ Scribed by Frank J. Gonzalez

Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
187 KB
Volume
43
Category
Article
ISSN
0270-9139

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

β-Catenin—A supporting role in the skele
β-Catenin—A supporting role in the skeleton
✍ Natasha Case; Janet Rubin 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 402 KB

## Abstract In the last 5 years a role for β‐catenin in the skeleton has been cemented. Beginning with mutations in the Lrp5 receptor that control β‐catenin canonical downstream signals, and progressing to transgenic models with bone‐specific alteration of β‐catenin, research has shown that β‐caten

WNT/β-catenin signaling in liver health
WNT/β-catenin signaling in liver health and disease
✍ Michael D. Thompson; Satdarshan P. S. Monga 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 304 KB

Wnt/␤-catenin signaling is emerging as a forerunner for its critical roles in many facets of human biology. Its roles in embryogenesis, organogenesis, and maintaining tissue and organ homeostasis demonstrate its munificent character. Its roles in pathological conditions such as cancer and other huma

The Wnt/β-catenin pathway: master regula
The Wnt/β-catenin pathway: master regulator of liver zonation?
✍ Zoë D. Burke; David Tosh 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 279 KB 👁 1 views

The liver contains two systems for the removal of ammonia-the urea cycle and the enzyme glutamine synthetase. These systems are expressed in a complementary fashion in two distinct populations of hepatocytes, referred to as periportal and perivenous cells. One of the unresolved problems in hepatolog

The role of immunomodulation in ABO-inco
The role of immunomodulation in ABO-incompatible adult liver transplant recipients
✍ Lucio Urbani; Alessandro Mazzoni; Irene Bianco; Tiziana Grazzini; Paolo De Simon 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 109 KB 👁 2 views

## Abstract ## Background: ABO‐incompatible (ABO‐i) liver transplantation (LT) is a high‐risk procedure due to the potential for antibody‐mediated rejection (AMR) and cell‐mediated rejection. The aim of the current report is to illustrate the results of a retrospective comparison study on the use